CERRITOS, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology practices in the country, today announced that Dr. Daniel Virnich, TOI’s Chief Executive Officer, will participate at the following investor conferences:
Jefferies Global Healthcare Conference
Date: June 6th, 2024
Fireside Chat: 9:00am Eastern Time
TOI Participant: Daniel Virnich, M.D., MBA, Chief Executive Officer
Location: New York City, NY
Truist Securities Healthcare Disruptors & Digital Health Summit
Date: June 26th, 2024
Panel: 1:00pm Eastern Time
TOI Participant: Daniel Virnich, M.D., MBA, Chief Executive Officer
Location: New York City, NY
Interested investors and other parties may listen to simultaneous webcasts of the presentations by logging onto the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/. The online replay will be available for a limited time shortly following the call.
About The Oncology Institute, Inc.
Founded in 2007, The Oncology Institute, Inc. and its affiliates (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of more than 1.8 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 110+ employed clinicians and over 70 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.
Contacts
Investors
Solebury Strategic Communications
investors@theoncologyinstitute.com
